Mehtap Dogan Canastar

Mehtap Canastar practices at Novant Health Pender Medical Center in Burgaw, North Carolina, part of Novant Health.

Mehtap Canastar's NPI, 1548657422, was assigned on April 18, 2015. Mehtap Canastar holds North Carolina license 2021-01612.

Mehtap Canastar's primary practice is Novant Health Pender Medical Center, at 507 E Fremont St, Burgaw, NC 28425 in Pender County. The practice phone is (910) 300-4004.

Mehtap Canastar's primary practice is Novant Health Pender Medical Center in Burgaw, North Carolina, part of Novant Health. Mehtap Canastar is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI also links Mehtap Canastar to 1 more hospital, 1 group practice or clinic, 1 senior living community, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mehtap Canastar practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Mehtap Canastar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Mehtap Canastar is licensed in North Carolina.

CMS data shows 966 Medicare services from Mehtap Canastar across 22 procedure codes in 2024, for 557 Medicare patients. Medicare paid $82,810 for them.

CMS counts 557 Medicare patients who saw Mehtap Canastar in 2024. The largest group is 65 to 74, with 285 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mehtap Canastar's median patient age at 69, with 64% women.

In 2024, Mehtap Canastar wrote 811 Medicare Part D claims for 242 patients. 89% of them were for generic drugs. CMS names the drug for 672 of them, across 9 drugs with 11 or more claims each, at $157,899 in total drug cost. In 2023, CMS named 643 claims across 10 drugs.

Mehtap Canastar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 281 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Mehtap Canastar, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Mehtap Canastar, published from 2020 to 2022. The most frequent topics are Heart Failure and Liver Cirrhosis. Mehtap Canastar has published most often in Cardiol Rev. Mehtap Canastar's most frequent co-authors are Edward Lebovics, MD, Abhay Dhand, MD and Anthony Gerard Gilet, MD.

CMS Open Payments shows 4 general payments to Mehtap Canastar from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $148.